ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (AP-HP);ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
发明人:
FRANK, MICHAEL
申请号:
CA3083432
公开号:
CA3083432A1
申请日:
2018.12.19
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The present disclosure relates to the field of treatment of an orphan disease, in particular treatment of vascular Ehlers-Danlos syndrome (vEDS). More specifically, the present disclosure relates to novel up-titration dosage regimens (e.g., escalating dosage regimens) effective for treating vEDS patients with celiprolol.